Baraclude Side Effects
Generic Name: entecavir
Please note - some side effects for Baraclude may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
Side Effects of Baraclude - for the Consumer
Baraclude
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Baraclude:
Seek medical attention right away if any of these SEVERE side effects occur when using Baraclude:Diarrhea; dizziness; drowsiness; headache; indigestion; nausea; tiredness; trouble sleeping; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dark-colored urine; difficulty breathing; fast or irregular heartbeat; feeling cold, especially in the arms or legs; light-colored bowel movements; loss of appetite for several days; muscle pain; severe dizziness or lightheadedness; severe or prolonged nausea or vomiting; severe tiredness; stomach pain (with or without nausea or vomiting); weakness; yellowing of the skin or eyes.
Baraclude Solution
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Baraclude Solution:
Seek medical attention right away if any of these SEVERE side effects occur when using Baraclude Solution:Diarrhea; dizziness; drowsiness; headache; indigestion; nausea; tiredness; trouble sleeping; vomiting.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dark-colored urine; difficulty breathing; fast or irregular heartbeat; feeling cold, especially in the arms or legs; light-colored bowel movements; loss of appetite for several days; muscle pain; severe dizziness or lightheadedness; severe or prolonged nausea or vomiting; severe tiredness; stomach pain (with or without nausea or vomiting); weakness; yellowing of the skin or eyes.
Baraclude Side Effects - for the Professional
Baraclude
- Most common adverse reactions (≥3%, all severity grades) are headache, fatigue, dizziness, and nausea. (6.1)
To report SUSPECTED ADVERSE REACTIONS, contact Bristol-Myers Squibb at 1-800-721-5072 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Side Effects by Body System
General
The most common side effects reported during clinical trials have included headache, fatigue, dizziness, and nausea. One percent of patients discontinued treatment due to side effects or laboratory abnormalities (compared to 4% of lamivudine-treated patients).
Hepatic
Hepatic side effects have included elevations in ALT (greater than 10 times ULN, 2%; greater than 5 times ULN, 5%), AST (greater than 5 times ULN, 5%), bilirubin (greater than 2.5 g/dL, 2% to 3%), amylase (greater than or equal to 2.1 times ULN, 2% to 3%), lipase (greater than or equal to 2.1 times ULN, 7%), ALT flares (2%), and alkaline phosphatase (greater than or equal to 5.1 times ULN, less than 1%). Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside/nucleotide analogs alone or in combination with other antiretroviral agents. Severe acute exacerbations of hepatitis have been reported in patients with hepatitis B after discontinuation of entecavir.
Posttreatment exacerbations of hepatitis, as defined by ALT greater than 10 times ULN and greater than 2 times baseline, have been reported in patients who discontinued treatment at or after 52 weeks after achieving a defined treatment response (nucleoside-naive HBeAg-positive, 2%; nucleoside-naive HBeAg-negative, 8%; lamivudine-refractory, 12%). The median time to exacerbation was 23 to 24 weeks. The rate may be higher in patients who discontinue entecavir without regard to treatment response.
Genitourinary
Genitourinary side effects have included hematuria (9%), glycosuria (4%), and dysuria.
Nervous system
Nervous system side effects have included headache (2% to 4%), dizziness, and somnolence.
Other
Other side effects have included fatigue (1% to 3%), fever, accidental injury, influenza, and back pain.
Hematologic
Hematologic side effects have included decreased platelets (less than 1%).
Metabolic
Metabolic side effects have included fasting hyperglycemia greater than 250 mg/dL (2% to 3%) and decreased serum albumin.
Renal
Renal side effects have included serum creatinine increases of 0.5 mg/dL or more (1% to 2%).
Gastrointestinal
Gastrointestinal side effects have included upper abdominal pain and Grade 2 to 4 diarrhea (1% or less), dyspepsia (1% or less), nausea (less than 1%), and vomiting (less than 1%). Abdominal pain (unspecified) has also been reported.
Oncologic
Oncologic side effects have included malignant neoplasms occurring at a rate of 8.4 per 1000 patient-years.
Respiratory
Respiratory side effects have included upper respiratory tract infection, cough, nasopharyngitis, and rhinitis.
Psychiatric
Psychiatric side effects have rarely included insomnia.
Dermatologic
Dermatologic side effects have included erythema. Rash and alopecia have been reported during postmarketing experience.
Hypersensitivity
Hypersensitivity side effects have included photosensitivity with lethargy in at least one patient, which resolved after stopping entecavir.
TopMore resources:
Baraclude - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
A to Z Drug List
Drugs by Condition
Drug Side Effects
Natural Products
Community Forums
Interactions Checker
MedNotes
Support Groups
Drug Image Search
Phonetic Search
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Clinical Trial Results
Medical Encyclopedia
News Feeds
Drugs by Classification
Patient Care Notes
Drug Imprint Codes
Medical Dictionary
Subscribe to our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.
